Walgreen is acquiring Express Scripts' home infusion pharmacy division.
Walgreen Co. announced a definitive agreement under which its subsidiary OptionCare Enterprises Inc. will acquire Express Scripts Inc.'s Louisville, Ky.-based home infusion pharmacy division, CuraScript Infusion Pharmacy. Terms of the agreement were not disclosed. The acquisition will further expand Walgreens home infusion services by providing greater access for its patients and payors. The parties expect the transaction to close within 30 days. CuraScript Infusion Pharmacy, a wholly owned subsidiary of Express Scripts, is one of the nation's largest providers of infusion services. Walgreens will acquire each of CuraScript IP's 12 facilities located in Alabama, Indiana, Kentucky, Missouri, Ohio, and Tennessee.